Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016. 2021

Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato

Latino adults, especially immigrants without citizenship (i.e., noncitizens), experience considerable barriers to health care, including medications. Inequitable access to medications, especially statins, may exacerbate disparities in cardiovascular disease. Despite this, little is known about medication nonadherence in Latino neighborhoods, especially those with large noncitizen populations. To estimate nonadherence to statins in Latino neighborhoods and evaluate differences on the basis of their noncitizen population. We conducted a retrospective cohort study among 48,161 adults who lived in predominately Latino neighborhoods in New York City, Los Angeles, and Chicago and who initiated statin therapy from January 2012 to December 2015 using IQVIA LifeLink. Statin nonadherence was defined as a proportion of days covered amounting to less than 80% over 12 months. We focused on differences between neighborhoods with high noncitizen concentrations (areas where noncitizens are at least 35% of the adult population) and other Latino neighborhoods. We examined associations using logistic regressions adjusted for individual (e.g., payment method) and neighborhood characteristics (e.g., poverty). Individuals living in neighborhoods with high noncitizen concentrations were more nonadherent to statins than those in Latino neighborhoods with fewer noncitizens (75.0% vs. 70.0%, adjusted odds ratio [aOR] 1.18, [95% CI 1.06-1.33]). These disparities were worse in New York City (77.7% vs. 69.1%, aOR 1.37, [95% CI 1.23-1.53]) and Chicago (76.1% vs. 68.8%, aOR 1.38, [95% CI 1.14-1.67]) than in Los Angeles (73.8% vs. 71.3%, aOR 1.10, [95% CI 1.01-1.20]). Neighborhoods with large noncitizen populations have much higher rates of statin nonadherence than Latino neighborhoods with fewer noncitizens. These disparities were least pronounced in Los Angeles, where the county provides health care to all uninsured residents, including noncitizens without documentation to reside in the United States. Efforts to improve medication access in Latino neighborhoods should be multifocal and start by implementing state and local health care options for low-income residents, regardless of citizenship status.

UI MeSH Term Description Entries
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D012111 Residence Characteristics Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services. Community,Domicile,Living Arrangements,Neighborhood,Place of Birth,Residential Selection,Arrangement, Living,Birth Place,Communities,Domiciles,Living Arrangement,Neighborhoods,Residence Characteristic
D002641 Chicago A city in Illinois.
D006630 Hispanic or Latino A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Cuban Americans,Hispanic Americans,Latin Americans, US,Latinas,Latinos,Latinx,Puerto Ricans,Spanish Americans,Hispanics,American, Hispanic,American, US Latin,Cuban American,Hispanic American,Hispanic or Latinos,Latin American, US,Latina,Latino,Puerto Rican,Spanish American,US Latin American,US Latin Americans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015141 Los Angeles City in California.
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
February 2020, Environment & planning A,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
December 2016, Social forces; a scientific medium of social study and interpretation,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
January 2021, Journal of the American Pharmacists Association : JAPhA,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
January 2021, The American journal of emergency medicine,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
December 1973, Science (New York, N.Y.),
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
May 2004, The Journal of infectious diseases,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
October 2006, Environmental health perspectives,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
May 2010, Health & place,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
April 2018, Injury epidemiology,
Jenny S Guadamuz, and Ramon A Durazo-Arvizu, and Martha L Daviglus, and Gregory S Calip, and Edith A Nutescu, and Dima M Qato
October 2005, American journal of public health,
Copied contents to your clipboard!